Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations

Pedro A Pousa1, Tamires S C Mendonça1, Eduardo A Oliveira2

  • 1Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Laboratório Interdisciplinar de Pesquisa Médica, Belo Horizonte, MG, Brazil.

Jornal De Pediatria
|September 27, 2020
PubMed

Insights

COVID-19 in children commonly affects systems beyond the lungs, with gastrointestinal and renal issues being most frequent. Understanding these extrapulmonary manifestations is crucial for pediatric care.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Immunology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has presented unique challenges in pediatric populations.
  • While respiratory symptoms are common, extrapulmonary manifestations in children require further investigation.

Purpose of the Study:

  • To review and summarize the most frequent extrapulmonary manifestations observed in pediatric COVID-19 cases.
  • To discuss the clinical, epidemiological, and pathophysiological characteristics of these non-respiratory presentations in children.

Main Methods:

  • A comprehensive literature search was conducted on PubMed for pediatric COVID-19 cases with extrapulmonary involvement.
  • The search covered articles published between January 1, 2020, and June 21, 2020, using relevant keywords and age filters.
  • Data from 28 articles, encompassing 199 pediatric patients, were reviewed and synthesized.

Main Results:

  • Gastrointestinal, renal, cardiovascular, and neurological systems were the most commonly affected non-pulmonary sites in pediatric COVID-19.
  • Hematological, lymphatic, cutaneous, hepatic, ocular, olfactory, and gustatory systems also showed involvement.
  • Multisystem inflammatory syndrome and Kawasaki-like disease were noted in some pediatric cases.

Conclusions:

  • Pediatric COVID-19 exhibits diverse extrapulmonary manifestations, influenced by children's unique immune responses.
  • Variations in angiotensin-converting enzyme 2 (ACE2) receptor expression may contribute to differing disease patterns in children.
  • Further research into these aspects is essential for effective pediatric management of COVID-19.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K